HESI LPN
Nutrition Final Exam Quizlet
1. How should the healthcare provider respond to a parent concerned about a child's short stature?
- A. Suggest the parent consult a nutritionist
- B. Recommend frequent growth hormone injections
- C. Advise monitoring for a few years before intervention
- D. Refer for a genetic evaluation
Correct answer: C
Rationale: When a parent expresses concern about a child's short stature, the initial approach should involve advising monitoring for a few years before considering any interventions. This allows for observation of the child's growth pattern and any potential underlying issues. Suggesting a nutritionist (Choice A) may not be necessary if there are no signs of nutritional deficiencies. Recommending growth hormone injections (Choice B) is premature without proper evaluation and diagnosis. Referring for a genetic evaluation (Choice D) can be considered later if monitoring shows atypical growth patterns or other concerning factors.
2. What is the most effective therapy for maintaining remission of acute lymphoblastic leukemia?
- A. Surgery to remove enlarged lymph nodes
- B. Long-term chemotherapy
- C. Nutritional supplements to enhance blood cell production
- D. Blood transfusions to replace ineffective red cells
Correct answer: B
Rationale: The correct answer is B: Long-term chemotherapy. Long-term chemotherapy, specifically with methotrexate, is the most effective therapy for maintaining remission in acute lymphoblastic leukemia. Surgery to remove enlarged lymph nodes (Choice A) is not the primary treatment for leukemia. Nutritional supplements (Choice C) may support overall health but are not the mainstay therapy for maintaining leukemia remission. Blood transfusions (Choice D) are used to address anemia in some cases but are not the primary treatment for maintaining remission in acute lymphoblastic leukemia.
3. What type of vaccine should a child with a history of severe allergic reactions receive?
- A. Live attenuated vaccines
- B. Inactivated vaccines
- C. Subunit vaccines
- D. Recombinant vaccines
Correct answer: B
Rationale: Children with a history of severe allergic reactions should receive inactivated vaccines because they do not contain live pathogens. Live attenuated vaccines (choice A) contain weakened live pathogens and can potentially trigger an allergic reaction in sensitive individuals. Subunit vaccines (choice C) and recombinant vaccines (choice D) may contain components that could still trigger an allergic response in individuals with a history of severe allergies. Inactivated vaccines are the safest choice for individuals with a history of severe allergic reactions as they do not pose a risk of causing an allergic reaction due to the absence of live pathogens.
4. What is a common sign of congenital hip dysplasia in infants?
- A. Symmetrical hip movement
- B. Limited range of motion in the hip
- C. Swelling of the knees
- D. Dislocated patella
Correct answer: B
Rationale: Limited range of motion in the hip, often noted as a limitation in abduction, is a common sign of congenital hip dysplasia. This limitation is due to the abnormal development of the hip joint, affecting its movement. Symmetrical hip movement (Choice A) is not a characteristic sign of congenital hip dysplasia. Swelling of the knees (Choice C) is not typically associated with this condition. Dislocated patella (Choice D) refers to a different anatomical structure and is not a common sign of congenital hip dysplasia.
5. What is one major weakness of a laboratory-based study?
- A. The costs are typically prohibitive.
- B. Findings are difficult to replicate.
- C. Results from animal testing cannot be applied to human beings.
- D. Experimental variables cannot be easily controlled.
Correct answer: C
Rationale: One major weakness of laboratory-based studies is that results from animal testing cannot always be applied to human beings. This limitation arises due to the inherent biological differences between animals and humans, making the generalization of findings challenging. While costs may be a concern in some cases, they do not represent a universal weakness of laboratory-based studies. Findings in such studies can be replicated to ensure validity, and experimental variables can be effectively controlled in a laboratory setting. Choice C is the correct answer because the translatability of results from animal studies to humans is a significant challenge in laboratory-based research, impacting the direct application of findings to human health and well-being.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access